Cargando…
New medications development for smoking cessation
Diseases associated with nicotine dependence in the form of habitual tobacco use are a major cause of premature death in the United States. The majority of tobacco smokers will relapse within the first month of attempted abstinence. Smoking cessation agents increase the likelihood that smokers can a...
Autores principales: | Lengel, Dana, Kenny, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373598/ https://www.ncbi.nlm.nih.gov/pubmed/37519910 http://dx.doi.org/10.1016/j.addicn.2023.100103 |
Ejemplares similares
-
Epigenetic biomarkers for smoking cessation
por: Fang, Fang, et al.
Publicado: (2023) -
Smoking Cessation with Medication and Behaviour Therapy
por: Egici, Memet Taskin, et al.
Publicado: (2017) -
Effects of aging on the effectiveness of smoking cessation medication
por: Scholz, Jaqueline, et al.
Publicado: (2016) -
Lung cancer screening and smoking cessation efforts
por: Moldovanu, Dana, et al.
Publicado: (2021) -
Smoking cessation
por: Kaur, Kirandeep, et al.
Publicado: (2012)